Japanese journal of clinical oncology · 2026
Adverse impact of bladder biopsy on the rate of intravesical recurrences following radical nephroureterectomy for upper tract urothelial carcinoma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kanagawa Tomonori, Yonese Ichiro, Nakamura Takehiro, Shimizu Mai, Tanaka Rie, Kido Hajime, Shinoda Tsukasa, Sekiya Ken, Soma Takahiko, Toide Masahiro, Ito Masaya, Takazawa Ryoji, Koga Fumitaka
Аннотация
INTRODUCTION: Seeding and implantation are major mechanisms of intravesical recurrence (IVR) following the radical nephroureterectomy (RNU) of upper tract urothelial carcinoma (UTUC). We herein hypothesized that bladder biopsies (BB) may increase the IVR risk by promoting implantation in injured bladder mucosa.
PATIENTS AND METHODS: This retrospective study included 172 patients with UTUC with no history of bladder UC who underwent RNU between January 2010 and December 2024 at two institutions. The primary endpoint was the association between BB and IVR-free survival (IVRFS) after RNU. A directed acyclic graph (DAG) was generated to identify potential confounders and guide multivariable analysis, and sensitivity analyses using propensity score matching were performed.
RESULTS: Eighteen (10%) patients underwent BB prior to RNU due to a positive voided urine cytology finding and/or the presence of erythematous mucosa. Patients receiving BB had significantly shorter IVRFS than those without BB (3-year IVRFS rate: 14% vs. 69%; P < .001). On both DAG-guided and stepwise multivariable models, BB was independently associated with an increased IVR risk (hazard ratio: 2.55 and 4.00, respectively; both P < .005). In the propensity score-matched cohort, BB was also associated with a shorter IVRFS. Notably, IVR developed at the BB sites in 60% of the cases of IVR following BB.
CONCLUSIONS: BB is likely to increase the IVR risk in patients undergoing RNU for UTUC by promoting tumor cell implantation. Avoiding BB may be prudent unless both urine cytology and cystoscopic findings are highly suspicious for bladder carcinoma.
PATIENTS AND METHODS: This retrospective study included 172 patients with UTUC with no history of bladder UC who underwent RNU between January 2010 and December 2024 at two institutions. The primary endpoint was the association between BB and IVR-free survival (IVRFS) after RNU. A directed acyclic graph (DAG) was generated to identify potential confounders and guide multivariable analysis, and sensitivity analyses using propensity score matching were performed.
RESULTS: Eighteen (10%) patients underwent BB prior to RNU due to a positive voided urine cytology finding and/or the presence of erythematous mucosa. Patients receiving BB had significantly shorter IVRFS than those without BB (3-year IVRFS rate: 14% vs. 69%; P < .001). On both DAG-guided and stepwise multivariable models, BB was independently associated with an increased IVR risk (hazard ratio: 2.55 and 4.00, respectively; both P < .005). In the propensity score-matched cohort, BB was also associated with a shorter IVRFS. Notably, IVR developed at the BB sites in 60% of the cases of IVR following BB.
CONCLUSIONS: BB is likely to increase the IVR risk in patients undergoing RNU for UTUC by promoting tumor cell implantation. Avoiding BB may be prudent unless both urine cytology and cystoscopic findings are highly suspicious for bladder carcinoma.